Home/Pipeline/Neural Application

Neural Application

Neurological Disease Drug Discovery

CommercialActive

Key Facts

Indication
Neurological Disease Drug Discovery
Phase
Commercial
Status
Active
Company

About CytoTronics

Founded in 2019 and based in Cambridge, Massachusetts, CytoTronics is a private, platform-technology company focused on transforming cell biology discovery. Its core product, the Pixel™ system, integrates a semiconductor-to-live-cell interface with cloud-based analytics to provide unprecedented, data-rich insights into live cell function at scale. The company appears to be in an early-revenue stage, leveraging its technology to enable applications in neurological, cardiovascular, and oncology research, and has recently executed a strategic asset sale of a specific MEA technology to Axion BioSystems.

View full company profile